- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01934699
Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods
Intraprocedural Determination of Myocardial Vitality Using Speckle Tracking Echocardiography Compared to Two-time MRI Diagnostics
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Each patient with typical angina pectoris symptoms will get echocardiographic examination during the inclusion phase. If motion disorder of regional left ventricular myocardial wall is detected, patient will get coronary angiography (not study related, caused of typical angina pectoris symptoms and high probability of CHD). If coronary stenosis related to motion disorder is available, patient will be randomized in two groups during coronary angiography.
- First Group: Patient will get echocardiographic examination during coronary angiography. 2D-Strain Analysis will be performed based on data of this echocardiographic examination. Only when vitality in the contraction impaired segments will be established based on 2D-Strain Analysis, PCI (Percutaneous Coronary Intervention) will be performed.
- Second Group: Coronary angiography by patient will be canceled. Patients will get viability assessment using MRI(Magnetic resonance imaging) within the next 7 days. When vitality will be established with MRI, patient will get PCI (Percutaneous Coronary Intervention).
In addition, as part of a feasibility analysis, the possibility of a consolidation of data of coronary angiography with the ultrasound images will be researched by first group of patients. The aim is to simplify the visualization of the intraprocedural vitality detection. For this purpose, a position sensor based on electromagnetic fields (EMT) will be used during coronary angiography.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
NRW
-
Aachen, NRW, Tyskland, 52074
- University Hospital Aachen
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Typical angina pectoris symptoms
- Echocardiographic determination of regional motion disfunction of left ventricular wall
- Establishment of needly treatment of stenosis related to motion disorder based on coronar angiography.
- Feasibility of MRI-Examination.
- Patients which are legally competent and which are mentally able to understand the study staff
- Patients give their written consent
Exclusion Criteria:
- Allergy against contrast agent
- Patients with limited renal function(GFR < 60 ml/min)
- Acute or instable angina pectoris
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: MRI-Arm
Myocardial vitality determination based on MRI diagnostics.
|
Coronary angiography on patient will be canceled.
Patients will get viability assessment using MRI within the next 7 days.
When vitality will be established with MRI, patient will get PCI.
|
|
Experimentell: Echo-Arm
Myocardial vitality determination using echocardiography in combination with 2D-Strain Analysis.
|
Patient will get echocardiographic examination during coronary angiography.
2D-Strain Analysis will be performed based on data of these echocardiographic examination.
Only when vitality in the contraction impaired segments will be established based on 2D-Strain Analysis, PCI will be performed.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
State of health score
Tidsram: 6 month after diagnistics
|
State of health score will be determinated by all patients for the evaluation of clinical outcomes (using the standardized questionnaire on state of health (SF-36))6 months after clinical diagnostics.
|
6 month after diagnistics
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Left ventricular function (ejection function)
Tidsram: 6 month after diagnistics
|
Left ventricular function (ejection function) by all patients will be determinated 6 month after diagnostics.
|
6 month after diagnistics
|
|
End-diastolic and end-systolic volume.
Tidsram: 6 month after diagnostics
|
End-diastolic and end-systolic volume will be determined by all patients 6 month after diagnostics
|
6 month after diagnostics
|
|
Capture of Major Adverse Cardiac and Cerebrovascular Events(MACCE)
Tidsram: 18 month after diagnostics
|
It will be determined, whether all patients suffered any major adverse cardiac and cerebrovascular events (MACCE) inter alia stroke, myocardial infarction, death 18 month after diagnostics
|
18 month after diagnostics
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Michael Becker, MD, University Hospital, Aachen
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 10-004
- 00012377 (Annan identifierare: DIMDI-Nr.)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .